"Perfect Storm" Of Issues Driving Firms To Mull Non-U.S. Growth - Survey
This article was originally published in The Gray Sheet
Executive Summary
Economic uncertainty, policy changes and regulatory frustration over the 510(k) process are pushing device companies to explore moving more operations outside of the U.S., according to an industry survey
You may also be interested in...
Senate Subcommittee Explores Innovation Strategy, With Device Emphasis
Device, investor and technology leaders told a U.S. Senate subcommittee on June 22 that they want a more thoughtful national strategy on innovation competitiveness - one that increases collaboration between industry and university researchers and reforms often confusing regulatory roadblocks
Gephardt-Led Group Steps Up Medical Innovation Lobbying Effort
An advocacy group headed by former U.S. House Majority Leader Dick Gephardt is launching a coordinated lobbying effort to improve federal policies impacting medical innovation, including calls to strengthen the R&D tax credit and make FDA oversight more predictable
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”